Chemoinformaics analysis of trideca-1-11-diene-3-5-7-9-tetrayne
Molecular Weight | 164.207 | nRot | 0 |
Heavy Atom Molecular Weight | 156.143 | nRig | 6 |
Exact Molecular Weight | 164.063 | nRing | 0 |
Solubility: LogS | -4.855 | nHRing | 0 |
Solubility: LogP | 4.537 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 27.0443 |
nHD | 0 | BPOL | 8.02566 |
QED | 0.478 |
Synth | 4.484 |
Natural Product Likeliness | 2.432 |
NR-PPAR-gamma | 0.944 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.003 |
Pgp-sub | 0 |
HIA | 0.603 |
CACO-2 | -3.855 |
MDCK | 0.000127708 |
BBB | 0 |
PPB | 1.04166 |
VDSS | 1.342 |
FU | 0.0234945 |
CYP1A2-inh | 0.979 |
CYP1A2-sub | 0.181 |
CYP2c19-inh | 0.907 |
CYP2c19-sub | 0.704 |
CYP2c9-inh | 0.863 |
CYP2c9-sub | 0.982 |
CYP2d6-inh | 0.629 |
CYP2d6-sub | 0.845 |
CYP3a4-inh | 0.801 |
CYP3a4-sub | 0.315 |
CL | 4.712 |
T12 | 0.115 |
hERG | 0 |
Ames | 0.458 |
ROA | 0.769 |
SkinSen | 0.974 |
Carcinogencity | 0.389 |
EI | 0.99 |
Respiratory | 0.594 |
NR-Aromatase | 0.97 |
Antiviral | No |
Prediction | 0.694038 |